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A B S T R A C T
In endemic areas, leptospirosis can bemissed by erroneous clinical or laboratory diagnosis of arboviroses
or co-infections with arboviruses and an increase in mortality due to leptospirosis has already been
reported during arboviruses outbreaks. During the French Polynesian chikungunya virus outbreak in
2014–2015, two leptospirosis and chikungunya co-infections were reported, one of which was fatal.
Diagnosis of leptospiroses was delayed in the context of chikungunya outbreak. In the context of
arbovirus outbreak, the risk of misdiagnosis of leptospirosis is maximum and clinicians should initiate
early antibiotic therapy if leptospirosis is suspected. A delayed diagnosis of leptospirosis can be
responsible for fatal outcome. Leptospirosis should be considered even if dengue or chikungunya virus
infections are conﬁrmed by reference molecular testing
ã 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
The Paciﬁc region is a high endemic area for leptospirosis [1]
and arboviruses [2]. In French Polynesia, leptospirosis, caused by
Leptospira spp., occurs annually with a peak in the rainy season,
while arboviroses, caused by dengue (DENVs), chikungunya
(CHIKV) or Zika viruses, occur mainly during outbreaks. Because
of a non-speciﬁc clinical presentation, leptospirosis can be
misdiagnosed as arboviroses, especially dengue [3,4]. In addition,
leptospirosis can be missed by erroneous clinical or laboratory
diagnosis of arboviroses or co-infectionswith arboviruses [5–7]. To
illustrate this risk we report two co-infections with Leptospira spp.
and chikungunya virus that occurred during the CHIKV outbreak in
French Polynesia in 2014–2015 (about 60,000 infections) [8], in a
context of co-circulation with DENV serotypes 1 and 3. Both co-
infections occurred in December 2014, during the rainy season.
Cases
Patient 1, a 70-year-old man with a history of type 2 diabetes,
severe chronic renal failure, arterial hypertension and gout, was
hospitalized for severe sepsis. He had been unwell for three weeks
(asthenia and diffuse arthralgia) and had experienced diffuse
arthromyalgia for the past week. Members of his family had been
diagnosed with chikungunya infection. On admission, he pre-
sentedwith severe sepsis including respiratory, hepatic and severe
renal failures. Results of laboratory tests showed anemia (hemo-
globin: 11.6 g/dL), leukocytosis (14.9109/L) with predominance
of neutrophils, lymphopenia (700106/L) with associated stimu-
lated lymphocytes, thrombocytopenia (35109/L), raised liver
enzymes and bilirubin (aspartate aminotransferase: 97U/L, ala-
nine aminotransferase: 50U/L), total bilirubin: 46mmol/L, severe
renal failure (creatinine: 398mmol/L), hyperkalemia (4.8mmol/L),
increased C-reactive protein (351mg/L) and procalcitonin (34ng/
mL). Chest radiography showed a right basal consolidation and
perihilar inﬁltrates. Given the clinical picture and the absence of
any obvious focus of infection, leptospirosis was suspected. The
patient was treated with amoxicillin, intravenous saline and
oxygen therapy and was admitted to the intensive care unit. The
patient’s condition rapidlyworsened and he died ofmultiple organ
failure a few hours after admission.
Patient 2, a 77-year-old man with treated pharynx cancer,
presented with a one-week history of fever and myalgia. On
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admission, he was found to have septic shock, jaundice, and
hepatomegaly. Results of laboratory tests showed anemia (hemo-
globin: 9.7 g/dL), leukocytosis (37.1109/L) with predominance of
neutrophils, thrombocytopenia (5109/L), raised liver enzymes
and bilirubin (aspartate aminotransferase: 257U/L, alanine ami-
notransferase: 78U/L), total bilirubin: 370mmol/L, pancreatitis
(lipase: 1133UI/L), severe renal failure (creatinine: 776mmol/L),
hyperkalemia (5.5mmol/L) and increased C-reactive protein
(180mg/L). Abdominal echographywas normal. Chest radiography
showed a left basal condensation. The patient was treated with
piperacilline + tazobactam and second generation quinolone (cip-
roﬂoxacin), and required red blood cell and aphaeresis platelets
transfusion and continuous hemoﬁltration. Abdominal CT scan
showed acute pancreatitis. After conﬁrmation of leptospirosis,
antibiotic regimen was changed to amoxicillin. His condition
improved and he was discharged from the intensive care unit
10days later.
For both patients, diagnosis was performed by Leptospira spp.
and CHIKV detection from blood by real time PCR using
commercial kits for CHIKV (RealStar1 CHIKV, Altona Diagnostics)
and primers and probes previously reported for Leptospira spp. [9].
Both patients tested negative for DENV by reverse transcription
PCR [10].
Publication of identiﬁed clinical cases was approved by the
ethics committee of French Polynesia (N 61 CEPF), written consent
was obtained from the patients for publication.
Discussion
We report the ﬁrst cases of leptospirosis and chikungunya co-
infections, both conﬁrmed by molecular diagnosis.
The possibility of leptospirosis and chikungunya co-infections
was raised during the CHIKV outbreak in La Reunion Island, Indian
Ocean, in 2006. During this outbreak there was an excess of
leptospirosis mortality (from 6% for the past years to 38% during
the outbreak) resulting mainly from delays in diagnosis or
leptospirosis infections being initially mistaken for chikungunya,
while the annual number of reported cases was stable over the
period [11]. The increased fatality rate was speciﬁc to leptospirosis
and was not observed for other infectious diseases. The diagnosis
of leptospirosis could also have been delayed because of a delay in
consulting a doctor in the context of a chikungunya outbreak, as
was the case in our two patients. No leptospirosis and chikungunya
co-infection was reported during the outbreak in La Reunion.
Leptospirosis and dengue co-infections have been described in
Mexico [12], Barbados [6], India [13], Pakistan [14], Jamaica [15]
and Peru [16]; including fatal cases in Puerto Rico [5], Sri Lanka [17]
and India [13]. Increased mortality due to leptospirosis during
dengue outbreaks was observed in Barbados in 1995 [6], Brazil in
2006 [7] and Puerto Rico in 2010–2012 [5]. In Barbados,
leptospirosis mortality during a dengue outbreak was twice the
average suggesting that some leptospirosis cases were misdiag-
nosed and treated inappropriately. In Brazil, it was hypothesized
that, during the outbreak, the large number of dengue cases and
the publicity about dengue led tomissed diagnosis of leptospirosis;
within the ﬁrst days of the illness, 61% of leptospirosis patients
received a diagnosis of dengue [7]. During a dengue epidemic in
South India, the highest mortality (29.6%) was observed in dengue/
leptospirosis co-infected versus leptospirosis (14.6%) and dengue
(3.7%) infected patients [18]. Although difﬁcult to assess, the
impact of co-infection on case fatality rate of leptospirosis and
chikungunya could be inﬂuenced bya potential synergistic effect of
both pathogens, and/or a delayed diagnosis of one of the
pathogens.
These data conﬁrm that diagnostic confusion with dengue or
chikungunya had a detrimental effect on leptospirosis outcome
especially because antibiotic therapy in leptospirosis is widely
believed to provide the greatest beneﬁt when initiated in the
early phase of the disease [19]. For the two French Polynesian co-
infected patients, the diagnosis was delayed and performed at
admission in hospital because of severe sepsis. The ﬁrst patient
was unwell for three weeks and had experienced diffuse
arthromyalgia for the past week before admission in the setting
of similar cases in his family diagnosed as CHIKV infections and
the second patient presented with a one-week history of fever
and myalgia. CHIKV infection was initially suspected. In the
setting of chikungunya outbreak the patients do not [2_TD$DIFF][1_TD$DIFF]medical care,
had no standard blood tests nor received antibiotics within the
ﬁrst week post symptoms onset. We cannot excluded that both
patients were ﬁrst infected by CHIKV and then presented a
“chikungunya like syndrome” and by Leptospira sp in a second
time. A the time of admission, laboratory testing of both patients
yielded increase bilirubin, leukocytosis with predominance of
neutrophils, increased C-reactive protein, increase creatinine and
thrombocytopenia. These laboratory results are common in
leptospirosis but uncommon in chikungunya [20]. However, both
patients had severe thrombocytopenia. Rapid decrease of platelet
count is a warning sign of severe dengue [3], it is uncommon in
chikungunya but can be found in leptospirosis [4] and a slight
increased C-reactive protein can be found in chikungunya [21]. We
reported in Table 1 these laboratory abnormalities in leptospirosis,
chikungunya and dengue. In order to avoid such mistake we
recommend to patients to seek medical care during arboviruses
outbreaks in case of fever and arthralgia, especially during the
raining season because of the risk of leptospirosis being
misdiagnosed as dengue or chikungunya. If patients seek medical
care, we recommend to perform standard laboratory tests at initial
presentation of patients presenting with fever and arthralgia, even
in the context of arboviruses outbreak, including standard blood
count (to detect leukocytosis and thrombocytopenia), renal and
hepatic markers and C-reactive protein. We also recommend
reevaluation of the patients a few days after initial consultation.
Several studies have shown that leptospirosis is often
confused with dengue and remains underdiagnosed, as previous-
ly reported in other Paciﬁc Islands (Federated States of Micro-
nesia) [9]. Following a dengue fever outbreak in 2012, ﬁve
diagnosis of leptospirosis were made retrospectively from
172 dengue suspected patients [9].
The risk of misdiagnosis of leptospirosis is high if the diagnosis
of arboviruses relies only on serological assays due false positive
results for dengue. In addition, serological testing for leptospiro-
sis detects antibodies from the second week of illness, resulting in
false negative results at the acute phase of the disease, the risk is
higher when using rapid diagnostic tests that lack sensitivity and
speciﬁcity for dengue and leptospirosis [22].
In developing countries, including most of the Paciﬁc islands,
diagnosis at ambulatory health services are often based on
clinical ﬁndings only. In this setting and in regards to overlapping
clinical features of leptospirosis with dengue or chikungunya,
misdiagnosis are frequent.
Table 1
Laboratory abnomalities for patients 1 and 2 and comparisonwith mono infections
by Leptospira, chikungunya virus and dengue virus.
Laboratory abnormalities Leptospirosis Chikungunya Dengue
Leukocytosis ++ – –
Thrombocytopenia ++ – ++
Increased bilirubin + – –
Increased creatinine ++ – +
Increased
C-reactive protein
++ – (or slight increase) –
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During arboviruses outbreaks, the attack rate of infections is
usually high, especially when it occurs in a population with low
levels or no pre-existing immunity as during La Reunion and
French Polynesian CHIKV outbreaks. An increased rate of
leptospirosis is observed during heavy rainfall and ﬂooding [7].
In the setting of arbovirus outbreaks, especially when climatic
conditions favors leptospirosis emergence (as rainy season in
French Polynesia), even if DENV or CHIKV infections are
conﬁrmed by reference molecular testing, leptospirosis should
be considered if other symptoms or laboratory abnormalities
raise a suspicion of leptospirosis.
Early diagnosis of leptospirosis is essential in order to
implement appropriate treatment and reduce severity of illness
and mortality. During arboviruses outbreaks, diagnostic strategy
should systematically include leptospirosis as a differential
diagnosis of dengue-like illness and consider the possibility of
co-infection with arboviruses in endemic areas and in travelers
returning from these regions.
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